Lichen planopilaris: Epidemiology and prevalence of subtypes-a retrospective analysis in 104 patients;Lichen planopilaris: Epidemiologie und prävalenz seiner subtypen - eine retrospektive analyse an 104 patienten

JDDG - Journal of the German Society of Dermatology

Volumn 12, Issue 3, 2014, Pages 229-235

  Meinhard, Johanna ^a   Stroux, Andrea ^a   Lünnemann, Lena ^a   Vogt, Annika ^a   Blume Peytavi, Ulrike ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOIMMUNE DISEASE; AXILLA; EYEBROW; FEMALE; FRONTAL FIBROSING ALOPECIA; GERMANY; HAIR; HEPATITIS; HORMONE SUBSTITUTION; HUMAN; LICHEN (DISEASE); LICHEN PLANOPILARIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PUBIC BONE; SEX DIFFERENCE; SEX RATIO; AGE DISTRIBUTION; CLASSIFICATION; COMORBIDITY; HYPERTENSION; LICHEN PLANUS; METABOLIC DISEASES; MIDDLE AGED; REGISTER; RISK FACTOR; SCALP DERMATOSES; STATISTICS AND NUMERICAL DATA;

AGE DISTRIBUTION; COMORBIDITY; FEMALE; GERMANY; HORMONE REPLACEMENT THERAPY; HUMANS; HYPERTENSION; LICHEN PLANUS; MALE; METABOLIC DISEASES; MIDDLE AGED; PREVALENCE; REGISTRIES; RISK FACTORS; SCALP DERMATOSES; SEX DISTRIBUTION;

EID: 84895812536     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/ddg.12264     Document Type: Article

References (31)

1. Tan E, Martinka M, Ball N, Shapiro J,. Primary cicatricial alopecias: clinicopathology of 112 cases. J Am Acad Dermatol 2004; 50: 25-32.
2. Olsen EA, Bergfeld WF, Cotsarelis G, et al. of North American Hair Research Society (NAHRS)-sponsored Workshop on Cicatricial Alopecia, Duke University Medical Center, February 10 and 11, 2001. J Am Acad Dermatol 2003; 48: 103-10.
3. Baibergenova A, Donovan J,. Lichen planopilaris: update on pathogenesis and treatment. Skinmed 2013; 11: 161-5.
4. Matta M, Kibbi AG, Khattar J, et al. Lichen planopilaris: a clinicopathologic study. J Am Acad Dermatol 1990; 22: 594-8.
5. Mehregan DA, Van Hale HM, Muller SA,. Lichen planopilaris: clinical and pathologic study of forty-five patients. J Am Acad Dermatol 1992; 27: 935-42.
6. Kossard S,. Postmenopausal frontal fibrosing alopecia. Scarring alopecia in a pattern distribution. Arch Dermatol 1994; 130: 770-4.
7. Samrao A, Chew AL, Price V,. Frontal fibrosing alopecia: a clinical review of 36 patients. Br J Dermatol 2010; 163: 1296-300.
8. Assouly P, Reygagne P,. Lichen planopilaris: update on diagnosis and treatment. Semin Cutan Med Surg 2009; 28: 3-10.
9. Chew AL, Bashir SJ, Wain EM, et al. Expanding the spectrum of frontal fibrosing alopecia: a unifying concept. J Am Acad Dermatol 2010; 63: 653-60.
10. Bianchi L, Paro Vidolin A, Piemonte P, et al. Graham Little-Piccardi- Lassueur syndrome: effective treatment with cyclosporin A. Clin Exp Dermatol 2001; 26: 518-20.
11. Blume-Peytavi U, Tosti A, Trüb R, Whiting DA,. Hair Growth and Disorders, 1. Auflage, Springer-Verlag, 2008: 189-94.
12. Chiang C, Sah D, Cho BK, et al. Hydroxychloroquine and lichen planopilaris: efficacy and introduction of Lichen Planopilaris Activity Index scoring system. J Am Acad Dermatol 2010; 62: 387-92.
13. Manousaridis I, Manousaridis K, Peitsch W, Schneider S,. Individualizing treatment and choice of medication in lichen planus: a step by step approach. J Dtsch Dermatol Ges 2013; [Epub ahead of print].
14. Tchernev G, Tronnier M,. Steven Kossards postmenopausal frontal fibrosing alopecia (PFFA)-a therapeutic dilemma. Akush Ginekol (Sofiia) 2010; 49: 46-9.
15. Fitzpatrick T,. Soleil et peau. J Med Esthet 1975: 33.
16. Poblet E, Jimenez F, Pascual A, Pique E,. Frontal fibrosing alopecia versus lichen planopilaris: a clinicopathological study. Int J Dermatol 2006; 45: 375-80.
17. Conde, Fernandes I, Selores M, Machado S,. Frontal fibrosing alopecia: a review of eleven patients. Eur J Dermatol 2011; 21: 750-2.
18. Macdonald A, Clark C, Holmes S,. Frontal fibrosing alopecia: A review of 60 cases. J Am Acad Dermatol 2012; 67 (5): 955-61.
19. Moreno-Ramirez D, Camacho Martinez F,. Frontal fibrosing alopecia: a survey in 16 patients. J Eur Acad Dermatol Venereol 2005; 19: 700-5.
20. Cho BK, Sah D, Chwalek J, et al. Efficacy and safety of mycophenolate mofetil for lichen planopilaris. J Am Acad Dermatol 2010; 62: 393-7.
21. Spencer LA, Hawryluk EB, English JC, 3rd,. Lichen planopilaris: retrospective study and stepwise therapeutic approach. Arch Dermatol 2009; 145: 333-4.
22. Ladizinski B, Bazakas A, Selim MA, Olsen EA,. Frontal fibrosing alopecia: a retrospective review of 19 patients seen at Duke University. J Am Acad Dermatol 2013; 68: 749-55.
23. Al-Azzawi F, Palacios S,. Hormonal changes during menopause. Maturitas 2009; 63: 135-7.
24. Herold G,. Innere Medizin, Eigenverlag, 2007: Kapitel II: 268-9, Kapitel VIII: 622-30.
25. Rubsam K, Schroll A, Weisenseel P, et al. Lichen planus and hepatitis virus infections: causal association? J Dtsch Dermatol Ges 2011; 9: 464-8.
26. Volzke H, Ludemann J, Robinson DM, et al. The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area. Thyroid 2003; 13: 803-10.
27. Schumm-Dräger PM, Feldkamp J,. Schilddrüsenkrankheiten in Deutschland. Prävention und Gesundheitsförderung 2007; 2: 153-8.
28. Gartner R,. Inflammatory thyroid diseases. Pathophysiology, diagnosis and therapy. Internist (Berl) 2002; 43: 635-42, 44-51; quiz 52-3.
29. Janssen OE, Mehlmauer N, Hahn S, et al. High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Eur J Endocrinol 2004; 150: 363-9.
30. Miteva M, Aber C, Torres F, Tosti A,. Frontal fibrosing alopecia occurring on scalp vitiligo: report of four cases. Br J Dermatol 2011; 165: 445-7.
31. Kruger C, Schallreuter KU,. A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol 2012; 51 (10): 1206-12.